abrdn Global Dynamic Dividend
NYSE:AGDAbrdn Global Dynamic Dividend Fund is a closed ended equity mutual fund launched and managed by Alpine Woods Capital Investors, LLC. It invests in the public equity markets across the globe. The fund invests in stocks of companies operating across diversified sectors. It invests in growth and value stocks of companies across all market capitalizations. The fund employs a fundamental analysis with bottom up and top down stock picking approach, focusing on companies globally with potential for dividend increases and capital appreciation to create its portfolio. It benchmarks the performance of its portfolio against the S&P 500 Index, MSCI AC World Daily TR (Net Div) Index, and MSCI AC World Daily TR ex Japan (Gross Div) Index. Abrdn Global Dynamic Dividend Fund was formed on May 11, 2006 and is domiciled in the United States.
Pacific Booker Minerals
CVE:BKMPacific Booker Minerals Inc. engages in the exploration of mineral properties in Canada. The company primarily explores for copper, gold, and molybdenum deposits. It holds interests in the Morrison property located in British Columbia. The company was formerly known as Booker Gold Explorations Limited and changed its name to Pacific Booker Minerals Inc. in February 2000. Pacific Booker Minerals Inc. was incorporated in 1983 and is headquartered in Vancouver, Canada.
Penumbra
NYSE:PENPenumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX Select, BENCHMARK, BMX96, BMX81, DDC, SENDit, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization Device, aspiration tubing, and aspiration pump under the Penumbra RED, JET, ACE, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that includes the Penumbra Coil 400, a detachable coil that provides an alternative for the treatment of aneurysms and other complex lesions, as well as Penumbra SMART COIL, a detachable coil to treat patients with a wide range of neurovascular lesions; and POD400 and PAC400 brands. In addition, the company provides peripheral embolization products, such as Ruby Coil System consisting of detachable coils for peripheral applications; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers an immersive 3D computer-based technology platform under the real immersive system brand; and neurosurgical tools, such as Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.
Valeant Pharmaceuticals International
TSE:VRXValeant Pharmaceuticals International, Inc. operates as a multinational, specialty pharmaceutical, and medical device company that develops, manufactures, and markets a range of pharmaceuticals, over-the-counter (OTC) products, and medical devices. The company operates through three segments: Bausch + Lomb/International, Branded Rx, and U.S. Diversified Products. The Bausch + Lomb/International segment provides pharmaceutical products, OTC products, and medical device products, primarily consist of Bausch + Lomb products, with a focus on the vision care, surgical, consumer, and ophthalmology Rx products in the United States; and pharmaceutical products, generic pharmaceutical products, OTC products, medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Australia and New Zealand, Latin America, Africa, and the Middle East. The Branded Rx segment sells gastrointestinal and dermatological products in the United States. The U.S. Diversified Products segment offers pharmaceutical products, OTC products, and medical device products in the areas of neurology and certain other therapeutic classes, including aesthetics. The company was founded in 1983 and is headquartered in Laval, Canada.
Wealth Minerals
CVE:WMLWealth Minerals Ltd., a junior mineral resource exploration company, engages in the acquisition, exploration, and development of mineral properties in Canada, Chile, Peru, and Mexico. The company primarily explores for lithium, as well as for precious metal and copper deposits. Its flagship property is the 100% owned Atacama project that comprises 144 exploration concessions covering an area of approximately 46,200 hectares located in the Atacama Salar in Region II of Antofagasta, northern Chile. Wealth Minerals Ltd. was incorporated in 1994 and is headquartered in Vancouver, Canada.